Thus, Theramir's technologies have the potential to revolutionize the precision oncology field by creating new knowledge on the pathology of the disease and enabling the customization and personalization of cancer treatment. With a focus on the biopharma, biotechnology, and pharmaceutical industries, Theramir presents an exciting opportunity for investors looking to support groundbreaking advancements in cancer therapeutics and diagnostics. As of now, there is no public information available regarding the last investment and last investment investors.
Theramir Ltd
Developing novel microRNA based therapeutics and companion diagnostics for patients and healthcare providers
Founded 2016
Cyprus
8 employees
Biopharma, Biotechnology +1
Cyprus
8 employees
Biopharma, Biotechnology +1
General Information
Company Name
Theramir Ltd
Founded Year
2016
Location
Cyprus
Cyprus
Employees
8
Industries
Biopharma, Biotechnology, Pharmaceutical
Social
BounceWatch is an independent company data service, not affiliated with Theramir Ltd. To contact Theramir Ltd, visit theramir.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Theramir Ltd compare?
A PDF of Theramir Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Theramir Ltd soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Theramir Ltd on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Cyprus Market
Biopharma
About Theramir Ltd
Business keywords: microRNA, therapeutics, companion diagnostics, oncology, precision medicine, cancer treatment, personalized medicine, targeted therapy, oncoproteins, gene regulation, cancer research, biomarkers, pathology, precision oncology
No funding data available for Theramir Ltd yet.
Theramir Ltd Alternatives & Competitors
View All Alternatives
Theramir Ltd vs
OncXerna Therapeutics
United States
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients to novel,...
Venture round
8 employees
Biopharma, Biotechnology
Theramir Ltd vs
Bound Therapeutics
United States
Safe and effective next generation RNA therapeutics
3 employees
Biopharma, Biotechnology
Theramir Ltd vs
Viewpoint Molecular Targeting, Inc.
United States
Targeted α-Particle Radiotherapy for Cancer
Grant
10 employees
Biotechnology, Health Care
FAQ About Theramir Ltd
Developing novel microRNA based therapeutics and companion diagnostics for patients and healthcare providers
Theramir Ltd was founded in 2016.
Theramir Ltd is headquartered in Cyprus.
Theramir Ltd operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on microRNA, therapeutics, companion diagnostics and oncology.
Theramir Ltd has approximately 8 employees.
Top alternatives and competitors to Theramir Ltd include OncXerna Therapeutics , Bound Therapeutics, Viewpoint Molecular Targeting, Inc., BoomRay Pharmaceuticals, PMV Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Theramir Ltd and OncXerna Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Theramir Ltd, https://bouncewatch.com/company/theramir-ltd, updated 24 October 2024. When citing, please name BounceWatch and link this page.
